# The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial

> **NCT05101798** · PHASE2 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 7 (actual)

## Conditions studied

- Neoplasm
- Skull Base Neoplasm

## Interventions

- **DRUG:** 5-Aminolevulinic acid Hydrochloride

## Key facts

- **NCT ID:** NCT05101798
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-14
- **Primary completion:** 2022-12-25
- **Final completion:** 2022-12-25
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** NX Development Corporation closed the trial
- **Last updated:** 2025-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05101798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05101798, "The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05101798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*